Antimicrobial resistance - pharmacological solutions

Infection

Volumn 27, Issue SUPPL. 2, 1999, Pages

  Rubinstein, E ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

AGRICULTURE; ANTIBIOTIC RESISTANCE; BACTERIUM CONTAMINATION; CONFERENCE PAPER; ENZYME INDUCTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; PHARMACOEPIDEMIOLOGY; SENSITIVITY AND SPECIFICITY;

EID: 0032821638     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561668     Document Type: Conference Paper

References (31)

1. Gerding, D. N., Larson, T. A., Hughes, R. A., Weiler, M., Shanholtzer, C., Peterson, L. R.: Aminoglycoside resistance and aminoglycoside usage: ten years experience in one hospital. Antimicrob. Agents Chemother. 35 (1991) 1284-1290.
2. Shimizu, K., Jumada, T., Hsieh, W. C., Chung, H. Y., Chong, Y., Hare, R. S., Miller, G. H., Sabatelli, F. J., Howard, J.: Comparison of aminoglycoside resistance patterns in Japan, Formosa, Korea, Chile and the US. Antimicrob. Agents Chemother. 28 (1985) 282-288.
3. Haley, R. W., Hightower, A. W., Khabbaz, R. F., Thornsberry, C., Martone, W. J., Allen, J. R., Hughes, J. M.: Emergence of methicillin resistant Staphylococcus aureus in United States hospitals. Ann. Intern. Med. 97 (1982) 297-311.
4. Vasquez, V., Calderon, E., Rodriguez, R.: Chloramphenicol-resistant strains of Salmonella typhosa. N. Engl. J. Med. 286 (1972) 1220-1226.
5. Rao, P. S., Rajashekar, V., Varghese, G. K., Shivananda, P. G.: Emergence of multi drug resistant Salmonella typhi in rural southern India. Am. J. Trop. Med. Hyg. 48 (1993) 108-111.
6. Handsfield, H. H., Sandstrom, E. G., Knapp, J. S., Perrine, P. L., Whittington, W. L., Sayers, D. E., Holmes, K. K.: Epidemiology of penicillinase producing Neissera gonorrhoeae: analysis by autotyping and serogrouping. N. Engl. J. Med. 306 (1982) 950-954.
7. Knapp, J. S., Zenilman, J. M., Biddle, J. W., Perkins, G. H., DeWitt, W. E., Thomas, M. L., Johnson, S. R., Morse, J. A.: Frequency and distribution in the United States of Neisseria gonorrhoeae with plasmid-mediated high-level resistance to tetracycline. J. Infect. Dis. 155 (1987) 819-822.
8. Fox, K. K., Knapp, J. S., Holmes, K. K., Hook, E. W. 3rd., Judson, F. N., Thompson, S. E., Washington, J. A., Whittington, W. L.: Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J. Infect. Dis. 175 (1987) 1396-1403.
9. Ejlertsen, T., Skov, R.: The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children. APMIS 104 (1996) 557-562.
10. Guillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle-Kervroedan, F., Bouvenot, G., Eschwege, E.: Low dosage and long treatment duration of beta lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279 (1998) 365-370.
11. Arason, V. A., Kristianson, K. G., Sigurdsson, J. A., Stefansdottir, G., Molstad, S., Gudmunsson, S.: Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross-sectional prevalence study. BMJ 313 (1996) 387.
12. Huovinen, P., Seppala, H., Kataja, J., Klaukka, T.: The relationship between erythromycin consumption and resistance in Finland. Finnish study group for antimicrobial resistance. Ciba Found. Symp. 207 (1997) 36-41.
13. Seppala, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., Huovinen, P.: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish study group for antimicrobial resistance. N. Engl. J. Med. 377 (1997) 441-446.
14. Austin, D. J., Kristianson, K. G., Anderson, R. M.: The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Natl. Acad. Sci. USA 96 (1999) 1152-1156.
15. Martinez, E., de la Cruz, F.: Genetic elements involved in Tn2I site-specific integration, a novel mechanism for the dissemination of antibiotic resistance genes. EMBO J. 9 (1990) 1275-1281.
16. Gould, L. M.: A review of the role of antibiotic policies in the control of antibiotic resistance. J. Antimicrob. Chemother. 43 (1999) 359-365.
17. Shulman, J. A., Terry, P. M., Hough, C. E.: Colonization with gentamicin resistant Pseudomonas aeruginosa, pyocine type 5, in a burn unit. J. Infect. Dis. 124 (1971) 18-23.
18. Ridley, M., Lynn, R., Barrie, D., Stead, K. C.: Antibiotic resistance of Staphylococcus aureus and hospital antibiotic policies. Lancet i (1970) 230-233.
19. Barber, M., Dutton, A. A. C., Beard, M. A., Elmes, P. C., Williams, R.: Reversal of antibiotic resistance in hospital staphylococcal infections. BMJ 1 (1960) 11-17.
20. Bulger, R. J., Sherris, J. C.: Decreased incidence of antibiotic resistance among Staphylococcus aureus: a study in a university hospital over a nine year period. Ann. Intern. Med. 69 (1968) 1099-1108.
21. Meyer, K. S., Urban, C., Eagan, J. A., Beger, B. J., Rahal, J. J.: Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins. Ann. Intern. Med. 119 (1993) 353-358.
22. Rahal, J. J., Urban, C., Horn, D., Freeman, K., Segal-Maurer, A. S., Maurer, J. et al.: Class restriction of cephalosporins use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280 (1998) 1233-1237.
23. Levy, S. B.: Balancing the drug-resistant equation. Trends Microbiol. 2 (1994) 341-432.
24. Archibald, I., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F., Gaynes, R.: Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin. Infect. Dis. 24 (1997) 211-215.
25. Lipsitch, M., Levin, B. R.: The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41 (1997) 363-373.
26. Schentag, J. J., Birmingham, M. C., Paladino, J. A.: In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Semin. Respir. Infect. 12 (1997) 279-283.
27. Schentag, J. J., Strenkoski-Nix, L. C., Nix, D. E., Forrest, A.: Pharmacodynamic interactions of antibiotics alone and in combinations. Clin. Infect. Dis. 27 (1998) 40-46.
28. Lode, H., Borner, K., Koeppe, P.: Pharmacodynamics of fluoroquinolones. Clin. Infect. Dis. 27 (1998) 33-39.
29. Van Landuyt, H. W., Boelaert, J., Gilbert, B., Gordts, B., Verbuggen, A. M.: Surveillance of aminoglycoside resistance: European data. Am. J. Med. 80 (Suppl. 6B) (1986) 76-81.
30. Moody, M. M., De Jongh, C. A., Schimpf, S. C., Tillman, G. L.: Long term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli. JAMA 248 (1982) 1199-1202.
31. Katzensfein, D.: Combination therapies for HIV infection and genomic drug resistance. Lancet 350 (1997) 970-971.